Liu R H, Foster G, Cone E J, Kumar S D
Graduate Program in Forensic Science, University of Alabama at Birmingham, USA.
J Forensic Sci. 1995 Nov;40(6):983-9.
Internal standards are commonly used for the quantitative determination of drugs of abuse and their metabolites (drug/metabolite) in biological fluids and tissues by the selective ion monitoring (SIM) gas chromatography/mass spectrometry (GC/MS) procedure. Analogs of drugs/metabolites that are labeled with three or more deuterium atoms (isotopic analog) at appropriate positions are considered to be the most effective internal standards for these applications. Before a specific deuterated analog can be adopted as an internal standard in a GC/MS assay, the mass spectrum of the compound or its derivative must be evaluated along with the corresponding spectrum from the parent drug/metabolite. There should be an adequate number of sufficiently high-mass ions (typically three for the drug/metabolite and two for the isotopic analog) that can be attributed to each analyte, and these ions should be sufficiently free of interference from the other analyte of the pair (cross-contribution). Interferences may be caused by the presence of an isotopic impurity in the deuterated analog (extrinsic factor) or may be due to the ion fragmentation characteristics of the compound (intrinsic factor). The extrinsic factor may be corrected by the manufacturer with different synthetic methods and purification procedures, while the intrinsic factor may be partially or wholly corrected through the use of different chemical derivatives (sample preparation stage) or different ionization (GC/MS assay stage) procedures. In this study, pentobarbital/d5-pentobarbital is used as the exemplar analyte/deuterated analog pair to illustrate the ion selection and evaluation procedures. Full-scan mass spectra were employed for preliminary ion selection. SIM data were then used to calculate the extent, if any, of cross-contributions.(ABSTRACT TRUNCATED AT 250 WORDS)
内标物常用于通过选择性离子监测(SIM)气相色谱/质谱(GC/MS)程序对生物体液和组织中的滥用药物及其代谢物(药物/代谢物)进行定量测定。在适当位置标记有三个或更多氘原子的药物/代谢物类似物(同位素类似物)被认为是这些应用中最有效的内标物。在将特定的氘代类似物用作GC/MS分析中的内标物之前,必须评估该化合物或其衍生物的质谱以及母体药物/代谢物的相应质谱。每种分析物应有足够数量的高质量离子(通常药物/代谢物为三个,同位素类似物为两个),并且这些离子应充分不受该对中另一种分析物的干扰(交叉贡献)。干扰可能由氘代类似物中存在的同位素杂质(外在因素)引起,也可能归因于化合物的离子碎片化特征(内在因素)。外在因素可由制造商通过不同的合成方法和纯化程序进行校正,而内在因素可通过使用不同的化学衍生物(样品制备阶段)或不同的电离(GC/MS分析阶段)程序进行部分或全部校正。在本研究中,戊巴比妥/d5-戊巴比妥用作示例分析物/氘代类似物对,以说明离子选择和评估程序。全扫描质谱用于初步离子选择。然后使用SIM数据计算交叉贡献的程度(如有)。(摘要截断于250字)